Patil, Rashmee
University Hospitals Birmingham NHS Foundation Trust · Inserm · Université Paris Cité · Sorbonne Université · University of Oxford · Centre de Recherche des Cordeliers · Centre de Recherche sur l'Inflammation · Physiopathologie et pharmacotoxicologie placentaire humaine : Microbiote pré & post natal · University of Birmingham · Newcastle University
3 papers on CoChatORCID 0000-0002-8345-0263
Most cited papers
- Verified
A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis
Harrison, S. A., Bedossa, P., Guy, C. D., Schattenberg, J. M., Loomba, R., Taub, R., Labriola, D., Moussa, S. E., Neff, G. W., Rinella, M. E., et al. (2024) · New England Journal of Medicine
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 2,084
- Verified
Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
Harrison, S. A., Ruane, P. J., Freilich, B. L., Neff, G., Patil, R., Behling, C. A., Hu, C., Fong, E., de Temple, B., Tillman, E. J., et al. (2021) · Nature Medicine
Liver Disease Diagnosis and TreatmentFibroblast Growth Factor Research
Cited by 368
- Verified
A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis
Harrison, S. A., Ruane, P. J., Freilich, B., Neff, G., Patil, R., Behling, C., Hu, C., Shringarpure, R., de Temple, B., Fong, E., et al. (2023) · JHEP Reports
Liver Disease Diagnosis and TreatmentHepatitis C virus research
Cited by 110
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free